5 completed, 4 active not recruiting, 3 recruiting, 1 terminated. 13 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 5, Active not recruiting 4, Recruiting 3, Terminated 1 |
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Peripheral Blood: new trials by email Literature Review of Peripheral Blood trials Research Report on Peripheral Blood
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia | Phase 2 | Recruiting | City of Hope Medical Center | 35 | 2026-11-05 | 2026-10-08 |
| Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma Bendamustine, Pralatrexate, Bone Marrow Aspiration - Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 50 | 2026-04-27 | 2026-05-11 |
| Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Aplastic Anemia | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 1 | 2025-09-25 | 2026-05-22 |
| Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants Cyclophosphamide, Itacitinib, Peripheral Blood Stem Cell Transplantation - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Active not recruiting | City of Hope Medical Center | 20 | 2022-12-29 | 2026-10-14 |
| A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma | Phase 2 | Recruiting | Children's Oncology Group | 160 | 2021-07-13 | 2026-09-23 |
| A Study of N-acetylcysteine in Patients With COVID-19 Infection N-acetylcysteine, Peripheral Blood - Covid-19 | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 48 | 2020-05-01 | 2026-05-01 |
| Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy Abemaciclib, Nivolumab, Tumor biopsy - Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Washington University School of Medicine | 6 | 2019-05-29 | 2020-12-03 |
| Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma Bendamustine, Rituximab, Acalabrutinib - Mantle Cell Lymphoma | Phase 2 | Completed | Washington University School of Medicine | 13 | 2018-11-29 | 2026-04-21 |
| BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) BMS-813160, Nivolumab, Gemcitabine - Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 40 | 2018-08-31 | 2025-07-29 |
| Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma Autologous Hematopoietic Stem Cell Transplantation, Busulfan, Gemcitabine Hydrochloride - Plasma Cell Leukemia, Plasmacytoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 83 | 2015-09-14 | 2025-03-18 |
| Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma MK-3475 (neoadjuvant), Surgery, Intensity modulated radiation therapy - Cancer of Head and Neck, Head and Neck Cancer | Phase 2 | Completed | Washington University School of Medicine | 67 | 2015-03-25 | 2026-08-05 |
| Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies Fludarabine phosphate, Busulfan, Total-Body Irradiation - Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 62 | 2012-12-24 | 2025-10-30 |
| Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 97 | 2009-09-01 | 2026-11-18 |
Leukemia, Myeloid, Acute (3) · Myelodysplastic Syndromes (3) · Anemia, Aplastic (2) · Leukemia, Myelomonocytic, Chronic (2) · Multiple Myeloma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Primary Myelofibrosis (2) · Squamous Cell Carcinoma of Head and Neck (2) · Burkitt Lymphoma (1) · COVID-19 (1) · Carcinoma, Embryonal (1) · Choriocarcinoma (1) · Head and Neck Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1)
Washington University School of Medicine (4) · City of Hope Medical Center (2) · Fred Hutchinson Cancer Center (2) · Children's Oncology Group (1) · M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (13) · Australia (1) · Canada (1) · New Zealand (1)
Douglas R Adkins, M.D. (2) · Monzr M Al Malki (2) · Brad S Kahl, M.D. (1) · Dolores Grosso, RN, CRNP, DNP (1) · Farhad Ravandi-Kashani (1) · Kian-Huat Lim, M.D., Ph.D. (1) · Lorenzo Iovino, MD, PhD (1) · Neal Flomenberg, MD (1) · Rachel B. Salit, MD (1) · Santosha Vardhana, MD, PhD (1) · Shannon M MacDonald (1) · Yago L Nieto (1)
P30CA033572 (2), P50CA196510 (1), U10CA032102 (1), U10CA180886 (1), U10CA180888 (1)